Recent research focusing on Tirzepatide at a dosage of 40mg is shedding new light on its potential effects. Preliminary findings suggest that this higher dosage may amplify the drug's ability to regulate blood glucose, potentially offering greater outcomes for individuals with insulin resistance. Further research is underway to fully explore the lo